Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dipidolor
2. Dipydolor
3. Pirinitramide
4. Piritramid
1. Dipidolor
2. Pirinitramide
3. Dipiritramide
4. Piridolan
5. 302-41-0
6. R 3365
7. 2,2-diphenyl-4-(4-piperidino-4-carbamoylpiperidino)butyronitrile
8. 4rp92lyz2f
9. Ids-np-013
10. 1'-(3-cyano-3,3-diphenylpropyl)(1,4'-bipiperidine)-4'-carboxamide
11. Piritramide (inn)
12. (1,4'-bipiperidine)-4'-carboxamide, 1'-(3-cyano-3,3-diphenylpropyl)-
13. Piritramid
14. Piritramide [inn]
15. 1'-(3-cyano-3,3-diphenylpropyl)-(1,4'-bipiperidine)-4'-carboxamide
16. 1-(3-cyano-3,3-diphenylpropyl)-4-piperidin-1-ylpiperidine-4-carboxamide
17. R-3365
18. Piritramide [inn:ban:dcf]
19. Piritramida
20. Piritramidum
21. 1'-(3-cyano-3,3-diphenylpropyl)-[1,4'-bipiperidine]-4'-carboxamide
22. Piritramidum [inn-latin]
23. Piritramida [inn-spanish]
24. Einecs 206-124-3
25. Unii-4rp92lyz2f
26. Brn 0501362
27. Dea No. 9642
28. [1,4'-bipiperidine]-4'-carboxamide, 1'-(3-cyano-3,3-diphenylpropyl)-
29. Dipidolor (tn)
30. Piritramide [mi]
31. Piritramide [mart.]
32. Schembl26151
33. Piritramide [who-dd]
34. Chembl559288
35. Dtxsid00184293
36. Chebi:135699
37. Zinc538198
38. Db12492
39. D07288
40. Q416439
41. Isonipecotamide, 1-(3-cyano-3,3-diphenylpropyl)-4-piperidino-
42. 1-(3-cyano-3,3-diphenylpropyl)-4-(piperidin-1-yl)piperidine-4-carboximidic Acid
Molecular Weight | 430.6 g/mol |
---|---|
Molecular Formula | C27H34N4O |
XLogP3 | 3.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 430.27326172 g/mol |
Monoisotopic Mass | 430.27326172 g/mol |
Topological Polar Surface Area | 73.4 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 638 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
N02AC03
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N02 - Analgesics
N02A - Opioids
N02AC - Diphenylpropylamine derivatives
N02AC03 - Piritramide
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?